Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has shared an announcement.
Jubilant Pharmova Limited has announced the dispatch of letters to shareholders whose email addresses are not registered, informing them about the availability of the Annual Report for FY 2024-25 and the Notice of the 47th Annual General Meeting (AGM) on the company’s website. The AGM is scheduled for August 29, 2025, and will be conducted via video conferencing, allowing shareholders to participate remotely. This move ensures compliance with regulatory requirements and enhances shareholder engagement by providing easy access to important company documents.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality, serving markets globally with a diverse portfolio of products.
Average Trading Volume: 17,379
Technical Sentiment Signal: Strong Buy
Current Market Cap: 184.9B INR
Find detailed analytics on JUBLPHARMA stock on TipRanks’ Stock Analysis page.